Indian Journal of Dermatology
  Publication of IADVL, WB
  Official organ of AADV
Indexed with Science Citation Index (E) , Web of Science and PubMed
Users online: 2365  
Home About  Editorial Board  Current Issue Archives Online Early Coming Soon Guidelines Subscriptions  e-Alerts    Login  
    Small font sizeDefault font sizeIncrease font size Print this page Email this page
This article has been cited by
Samvedna Saini,Yatender Kumar
2Clinical and experimental evidence for targeting CD6 in immune-based disorders
Marta Consuegra-FernŠndez,Feng Lin,David A. Fox,Francisco Lozano
Autoimmunity Reviews.2018;17(5)493
3The landscape of novel and complementary targets for immunotherapy: an analysis of gene expression in the tumor microenvironment
Stephen G. Gaffney,Elizabeth B. Perry,Ping-Min Chen,Andrew Greenstein,Susan M. Kaech,Jeffrey P. Townsend
4Treatment Modalities of Psoriasis: A Focus on Requisite for Topical Nanocarrier
Arya K. Ramanunny,Sheetu Wadhwa,Divya Thakur,Sachin K. Singh,Rajesh Kumar
Endocrine, Metabolic & Immune Disorders - Drug Targets.2021;21(3)418
5A two-arm, randomized, controlled, multi-centric, open-label phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19
Suresh Kumar,Rosemarie De Souza,Milind Nadkar,Randeep Guleria,Anjan Trikha,Shashank R. Joshi,Subramanian Loganathan,Sivakumar Vaidyanathan,Ashwani Marwah,Sandeep N. Athalye
Expert Opinion on Biological Therapy.2021;21(5)675
6Asthmatic patientís preferences regarding frequency of physician consultation
Javeria Farooq,Sheikh Abdul Khaliq,Iqbal Azhar
Saudi Pharmaceutical Journal.2021;29(2)201
7Clinical course of critically ill non-COVID 19 ARDS patients using Itolizumab versus conventional treatment: A case series
Manimaran Rajendran
IP Indian Journal of Immunology and Respiratory Medicine.2022;7(2)93
  The Journal 
  The Association 
  Book of Abstracts 
  Site Statistics 
  My Preferences 
  Online Submission 

Submit Articles